Get the latest Science News and Discoveries
Genetically engineering a treatment for incurable brain tumors - EurekAlert
<p>Sandro Matosevic of Purdue University's College of Pharmacy leads a team developing and validating a patent-pending novel immunotherapy to be used against glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma. Matosevic is also on the faculty of the Purdue Institute for Cancer Research and the Purdue Institute for Drug Discovery. The Matosevic-led research has been published in the peer-reviewed journal Nature Communications.</p>
None
Or read this on Eureka Alert